Tamas Habon

Citat de

	Toate	Din 2019
Referințe bibliografice	2091	1211
h-index	25	19
i10-index	36	27

360

180

270

199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320249 8 16 25 29 43 47 74 61 52 71 60 62 43 46 31 38 42 39 58 112 145 204 258 354 134

Acces public

Afișați-le pe toate

15 articole

0 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Róbert Dr. Halmosifull professor, University of Pecs Medical SchoolAdresă de e-mail confirmată pe pte.hu
Gábor Késmárkyfull professor, 1st Department of Medicine, University of PécsAdresă de e-mail confirmată pe pte.hu
Peter HegyiProfessor of Medicine, Semmelweis University (SE, full time) & Pécs (PTE, part time), HungaryAdresă de e-mail confirmată pe semmelweis-univ.hu
Prof. Balázs SÜMEGI; DSCProfessor of Biochemistry; University of Pecs; Medical SchoolAdresă de e-mail confirmată pe aok.pte.hu
Marta BalaskoAssociate Professor of Pathophysiology, Institute for Translational Medicine, Medical SchoolAdresă de e-mail confirmată pe aok.pte.hu
Roland GalUniversity of Pecs, Medical Center, I. Department of Internal Medicine, Division of CardiologyAdresă de e-mail confirmată pe pte.hu
Andras GaramiAssociate Professor, Institute for Translational Medicine, University of Pecs, HungaryAdresă de e-mail confirmată pe aok.pte.hu
Dora Endreiegyetemi adjunktus , Pécsi TudományegyetemAdresă de e-mail confirmată pe pte.hu
Imre SzaboUniversity of PecsAdresă de e-mail confirmată pe pte.hu
Béla MeleghUniversity of PécsAdresă de e-mail confirmată pe pte.hu
Barbara SandorUniversitiy of PecsAdresă de e-mail confirmată pe pte.hu
Margit SolymárMedical School, University of PecsAdresă de e-mail confirmată pe aok.pte.hu
Judit TenkInstitute for Translational Medicine, Medical School, University of PécsAdresă de e-mail confirmată pe aok.pte.hu
Krisztina KovacsUniversity of PecsAdresă de e-mail confirmată pe aok.pte.hu
Balázs NémetiDepartment of Pharmacology, University of PécsAdresă de e-mail confirmată pe aok.pte.hu
Katalin KoltaiPTEAdresă de e-mail confirmată pe pte.hu
Dr. Borbély AttilaDebreceni Egyetem, Klinikai Központ, Kardiológiai és Szívsebészeti KlinikaAdresă de e-mail confirmată pe med.unideb.hu
Erika PetervariInstitute for Translational Medicine, University of Pecs, HungaryAdresă de e-mail confirmată pe aok.pte.hu
Zoltán RumbusInstitute for Translational Medicine, University of Pecs, HungaryAdresă de e-mail confirmată pe aok.pte.hu
Réka Dr. FaludiHeart Institute, Medical School, University of PecsAdresă de e-mail confirmată pe aok.pte.hu

Urmăriți

Tamas Habon

Associate professor, University of Pecs, Hungary

Adresă de e-mail confirmată pe pte.hu - Pagina de pornire

Cardiology


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
The heart failure association atlas: heart failure epidemiology and management statistics 2019 PM Seferović, P Vardas, EA Jankowska, AP Maggioni, A Timmis, ... European journal of heart failure 23 (6), 906-914, 2021	175	2021
Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat E Szabados, GM Fischer, K Toth, B Csete, B Nemeti, K Trombitas, ... Free Radical Biology and Medicine 26 (3-4), 309-317, 1999	173	1999
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double … JP Piccini, V Caso, SJ Connolly, KAA Fox, J Oldgren, WS Jones, ... The lancet 399 (10333), 1383-1390, 2022	168	2022
In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine B Horvath, Z Marton, R Halmosi, T Alexy, L Szapary, J Vekasi, Z Biro, ... Clinical neuropharmacology 25 (1), 37-42, 2002	149	2002
Glycoprotein IIIA Gene (PIA) Polymorphism and Aspirin Resistance: Is There Any Correlation? E Papp, V Havasi, J Bene, K Komlosi, L Czopf, E Magyar, C Feher, ... Annals of Pharmacotherapy 39 (6), 1013-1018, 2005	113	2005
Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound P Deres, R Halmosi, A Toth, K Kovacs, A Palfi, T Habon, L Czopf, T Kalai, ... Journal of cardiovascular pharmacology 45 (1), 36-43, 2005	99	2005
Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta‐analysis and systematic review B Erőss, N Farkas, Á Vincze, B Tinusz, L Szapary, A Garami, M Balasko, ... Helicobacter 23 (4), e12504, 2018	86	2018
The effect of serum triglyceride concentration on the outcome of acute pancreatitis: systematic review and meta-analysis L Kiss, G Fűr, P Mátrai, P Hegyi, E Ivány, IM Cazacu, I Szabó, T Habon, ... Scientific reports 8 (1), 14096, 2018	84	2018
Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ... Circulation 139 (6), 787-798, 2019	76	2019
Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and … L Szapary, B Horvath, Z Marton, T Alexy, G Kesmarky, T Habon, M Szots, ... CNS drugs 18, 165-172, 2004	69	2004
Management and 1‐year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: results from the prospective GARFIELD‐AF registry S Goto, P Angchaisuksiri, JP Bassand, AJ Camm, H Dominguez, ... Journal of the American Heart Association 8 (3), e010510, 2019	59	2019
The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals T Habon, E Szabados, G Kesmarky, R Halmosi, T Past, B Sumegi, K Toth Cardiovascular research 52 (1), 153-160, 2001	58	2001
Follow‐up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes Z Marton, B Horvath, T Alexy, G Kesmarky, ZS Gyevnar, L Czopf, T Habon, ... Clinical hemorheology and microcirculation 29 (2), 81-94, 2003	53	2003
Pancreatitis-associated genes and pancreatic cancer risk: a systematic review and meta-analysis IM Cazacu, N Farkas, A Garami, M Balaskó, B Mosdósi, H Alizadeh, ... Pancreas 47 (9), 1078-1086, 2018	50	2018
The effect of resveratrol on the cardiovascular system from molecular mechanisms to clinical results R Gal, L Deres, K Toth, R Halmosi, T Habon International journal of molecular sciences 22 (18), 10152, 2021	46	2021
Therapeutic whole-body hypothermia reduces death in severe traumatic brain injury if the cooling index is sufficiently high: meta-analyses of the effect of single cooling … E Olah, L Poto, P Hegyi, I Szabo, P Hartmann, M Solymar, E Petervari, ... Journal of Neurotrauma 35 (20), 2407-2417, 2018	46	2018
Effect of L-2286, a poly (ADP-ribose) polymerase inhibitor and enalapril on myocardial remodeling and heart failure E Bartha, GN Kiss, E Kalman, G Kulcsár, T Kálai, K Hideg, T Habon, ... Journal of cardiovascular pharmacology 52 (3), 253-261, 2008	46	2008
Hemorheological and hemodynamical parameters in patients with ischemic heart disease at rest and at peak exercise K Toth, T Habon, I Horvath, B Mezey, I Juricskay, GY Mozsik Clinical Hemorheology and Microcirculation 14 (3), 329-338, 1994	43	1994
Aging and comorbidities in acute pancreatitis I: a meta-analysis and systematic review based on 194,702 patients K Marta, AM Lazarescu, N Farkas, P Matrai, I Cazacu, M Ottoffy, T Habon, ... Frontiers in physiology 10, 328, 2019	39	2019
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry FWA Verheugt, H Gao, W Al Mahmeed, G Ambrosio, P Angchaisuksiri, ... European heart journal 39 (6), 464-473, 2018	38	2018

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori